Broadwood Capital Inc., 10% Owner at OncoCyte Corp (OCX), bought 7,936,508 shares at $1.26 ($10.0M) on 2018-03-28, disclosed to the SEC on 2018-03-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.26 | 3,968,254 | $5.0M | 50.0% |
| 2 | $1.26 | 3,968,254 | $5.0M | 50.0% |
| Total | $1.26 avg | 7,936,508 | $10.0M | 100% |
| Filing → |
| STAA | BUY | 2025-03-20 | $7.2M | — | Filing → |
| STAA | BUY | 2025-03-06 | $964K | — | Filing → |
| STAA | BUY | 2025-03-03 | $22.5M | — | Filing → |